Events

Speakers include Kevin Outterson, Executive Director of CARB-X. The Royal Swedish Academy of Engineering Sciences (IVA) is hosting the yearly conference for the International Council of Academies of Engineering and Technological Sciences (CAETS) in 2019. CAETS in a independent non-political, non-governmental international organization of engineering and technological science academies worldwide. The conference will focus on what […]

In this webinar, Dr Manica Balasegaram, GARDP’s Executive Director will highlight GARDP’s role in accelerating the implementation of WHO’s Global Action Plan, and share GARDP’s updated strategy. Following his presentation, you will have the opportunity to ask questions in a Q&A session moderated by Jennifer Katz, GARDP’s Director of External Affairs. Register here for this live webinar.

Additional Details Forthcoming.

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this webinar, Françoise van Bambeke, Research Director Cellular and Molecular Pharmacology, Louvain Drug Research Institute, Catholic University of Louvain (FR), will talk about intracellular activity of […]

Please share any pipeline additions and changes that you are aware of by 22 July 2019. Download and use this form to provide updates. The latest pipeline update (as of July 1, 2018), can be found as a manuscript (Theuretzbacher et al. Lancet ID 2018), and as a set of summary tables. Contact Sarah Paulin (paulins@who.int).

This is an open session hosted by the National Academy of Sciences, Engineering, and Medicine.  The 1.5-day public workshop to will be held on July 24-25, 2019 in Washington, D.C and focus on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in […]

Keynote lecture given by Kevin Outterson, Executive Director of CARB-X. Additional details forthcoming.

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this webinar, Lena Friberg and Elisabet Nielsen (Department of Pharmaceutical Biosciences, Uppsala University, Sweden), will discuss: Population PK modelling to characterize drug exposure and variability PKPD-modelling […]

The ASM/ECSMID Conference on Drug Development returns to Boston, Massachusetts for 2019. Check back soon for program details. Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by National and International bodies. There are relatively few agents in developmental pipelines and a paucity of […]

Sponsored by the Harvard Microbial Sciences Initiative and the Boston Area Antimicrobial Research Network Drinks, hors d'oeuvres, and exclusive private access to the Harvard Museum of Natural History https://hmnh.harvard.edu/. This is a chance to unwind with fellow attendees at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, and meet those […]